| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 53,391 | 59,928 | ||
| Prepaid expenses and other current assets | 975 | 1,101 | ||
| Total current assets | 54,366 | 61,029 | ||
| Property and equipment, net of accumulated depreciation of 1,030 and 891 | 226 | 271 | ||
| Restricted cash long term | 332 | 329 | ||
| Operating leases right-of-use assets | 1,215 | 1,373 | ||
| Finance leases right-of-use assets | 12 | 15 | ||
| Total assets | 56,151 | 63,017 | ||
| Accounts payable and accrued expenses | 6,224 | 7,714 | ||
| Operating leases current liability | 599 | 589 | ||
| Finance leases current liability | 11 | 11 | ||
| Total current liabilities | 6,834 | 8,314 | ||
| Long-term license revenue deferred | 35,000 | 35,000 | ||
| Long-term operating lease obligations | 531 | 685 | ||
| Long-term finance lease obligations | 2 | 5 | ||
| Total liabilities | 42,367 | 44,004 | ||
| Common stock, 0.001 par value 1,000,000,000 shares authorized 31,195,891 and 31,195,891 shares issued and outstanding, respectively | 31 | 31 | ||
| Additional paid-in capital | 417,526 | 417,624 | ||
| Accumulated deficit | -403,773 | -398,642 | ||
| Total stockholders equity | 13,784 | 19,013 | ||
| Total liabilities and stockholders equity | 56,151 | 63,017 | ||
Actinium Pharmaceuticals, Inc. (ATNM)
Actinium Pharmaceuticals, Inc. (ATNM)